GlaxoSmithKline (GB:GSK) has released an update.
GlaxoSmithKline (GSK) has announced its total number of voting rights, revealing a share capital of 4,314,215,315 Ordinary Shares as of June 30, 2024, with 169,171,155 shares held in Treasury. Consequently, the number of voting rights amounts to 4,145,044,160, which shareholders can use as a reference for declaring changes in their ownership interest per the Financial Conduct Authority’s rules.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.
